Department of Pharmacology & Toxicology, Wright State University, Dayton, OH, United States.
Department of Pathology, Wright State University, Dayton, OH, United States.
Dig Liver Dis. 2017 Aug;49(8):887-892. doi: 10.1016/j.dld.2017.03.023. Epub 2017 Apr 9.
Genetic and environmental factors contribute to the development of celiac disease (CD), but specific genetic predisposing factors remain poorly understood. One candidate is allele 2 of the hs1.2 enhancer within the immunoglobulin heavy chain region. In humans, there are four possible alleles and a previous study of an Italian cohort demonstrated a significantly increased frequency of allele 2 in patients with CD.
The purpose of the current study was to determine if a similar association between allele 2 and CD exists in an American population from Dayton, OH.
Subjects were screened for CD via esophagogastroduodenoscopy with duodenal biopsy. All biopsies were microscopically scored using a modified Marsh-Oberhuber classification. DNA was isolated from patients' buccal cells for hs1.2 genotype analysis using PCR.
Unlike the Italian cohort, allele 2 frequency was not significantly different in patients with histopathologic evidence of CD compared to patients without such evidence. However, our patient population as a whole demonstrated a significantly increased allele 2 frequency when compared to that previously reported within diverse ethnic populations.
Since our comparative control patients do not necessarily reflect a healthy control population, an overall increase in allele 2 may reflect an association between allele 2 of the hs1.2 enhancer and a spectrum of gastrointestinal disorders.
遗传和环境因素促成了乳糜泻(CD)的发生,但特定的遗传易感性因素仍知之甚少。一个候选因素是免疫球蛋白重链区域内 hs1.2 增强子的等位基因 2。在人类中,有四个可能的等位基因,之前对意大利队列的研究表明,CD 患者的等位基因 2频率显著增加。
本研究旨在确定在俄亥俄州代顿的美国人群中,等位基因 2 与 CD 之间是否存在类似的关联。
通过食管胃十二指肠镜检查和十二指肠活检对受试者进行 CD 筛查。所有活检均采用改良的 Marsh-Oberhuber 分类法进行显微镜评分。从患者的口腔细胞中提取 DNA,用于 hs1.2 基因型分析,采用 PCR 方法。
与意大利队列不同,与组织病理学证据为 CD 的患者相比,具有这种证据的患者的等位基因 2 频率没有显著差异。然而,与之前在不同种族人群中报告的频率相比,我们的患者群体整体上显示出等位基因 2 频率显著增加。
由于我们的对照患者不一定反映健康对照人群,因此等位基因 2 的总体增加可能反映了 hs1.2 增强子的等位基因 2 与一系列胃肠道疾病之间的关联。